Additionally, its ability to suppress TGF-β (Transforming Growth Factor Beta) signaling and promote collagen degradation can help in reducing the desmoplastic reaction, potentially improving the overall treatment response and patient outcomes in cancer therapy. This evidence concerns the gene TGFB1 and cancer.